Skip to main content

Table 1 Relationship between general clinical characteristics and circPDE5A level in patients with ESCC (n = 100)

From: CircPDE5A-encoded novel regulator of the PI3K/AKT pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1

General clinical characteristics

CircPDE5A expression

p-value

statistics

High (n = 50)

Low (n = 50)

Gender (%)

  

1

0

 Female

44 (88)

44 (88)

  

 Male

6 (12)

6 (12)

  

Age (mean ± SD)

58.6 ± 10.367

60.22 ± 10.938

0.449

-0.760

BMI (mean ± SD)

23.103 ± 4.12

22.752 ± 3.62

0.652

0.453

Smoke history (%)

22 (44)

28 (52)

0.423

0.641

Alcohol history (%)

35 (70)

29 (58)

0.211

1.563

Histologic Grade (G stage) (%)

  

0.249

1.329

 G1

9 (18)

5 (10)

  

 G2 + G3

41 (82)

45 (90)

  

T stage

  

0***

17.818

 T1 + T2

33 (66)

12 (24)

  

 T3 + T4

17 (34)

38 (76)

  

N stage

  

0***

14.586

 N0

32 (64)

13 (26)

  

 N1 + N2 + N3

18 (36)

37 (74)

  

M stage

  

0.056

5.263a

 M0

50 (100)

45 (90)

  

 M1

0 (0)

5 (10)

  

TNM stage

  

0***

36.946

 I + II

44 (88)

14 (28)

  

 III + IV

6 (12)

36 (72)

  
  1. BMI Body Mass Index, a Fisher exact probability test, *** p < 0.001